About CLS
News and insights
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2
Start Investor Relations Corporate Governance
Good corporate governance is central to ensuring that a company is managed in the right way. At CLS, we are very meticulous about having good and clear corporate governance so that our investors feel confident in the company and in the decisions that are made.
Prospectus and other documents in connection with forthcoming rights issue (June 2024) are available here:
The shareholders of Clinical Laserthermia Systems AB, 556705-8903, are hereby invited to an Extraordinary General Meeting on Monday, October 21, 2024, at 10:00 AM at Scheelevägen 4, Medicon Village, Lund.
Your subscription is now saved and you will recive an email to verify your email address and activate the subscription.
We could not save your subscriptions please go back and try again.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
©Copyright 2024 CLS AB. All rights reserved.
MM-2022-025/Rev2